B.C. initiative aims to expand genetic screening for Ashkenazi Jewish people at risk of hereditary cancers

By
1 Min Read
- Advertisement -
Ad image

The final gift Catriona Remocker’s father gave her was discovered by a lab in a vial of his blood.

Dr. Geoffrey Remocker died of Stage IV prostate cancer in 2016, just two weeks after testing confirmed he was a carrier for genetic mutations that increase the likelihood of developing ovarian, breast, prostate and pancreatic cancers.

These hereditary BRCA1 and BRCA2 mutations are ten times more common among both men and women of Ashkenazi Jewish descent, like Remocker and her father, than non-Jewish people.

About one in 40 individuals with Ashkenazi heritage carry the mutations, according to the U.S. Centre for Disease Control, which increase

- Advertisement -
Share This Article
Follow:
WNews is a digital and print newsroom committed to investigative, balanced, and honest journalism. Our team covers breaking news, politics, global affairs, community stories, and in-depth investigations across Canada, the United States, and around the world. From frontline reporting to long-form analysis, WNews delivers coverage that prioritizes truth, accuracy, and transparency. Our mission is simple: bring news back to news and restore trust in a time when it matters most. Follow our latest reports at W.News and across all WNews platforms.
- Advertisement -
Ad image
Leave a Comment
Report a Error with this Story

Notice a error or facts with this story, please submit the information below and someone from our newsroom will review it and change if required 

Reading: B.C. initiative aims to expand genetic screening for Ashkenazi Jewish people at risk of hereditary cancers

(C) 2012 – 2024  | WNews Broadcasting Corp, a W-World Company | All Rights Reserved

Connect
with Us